Stay updated on Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new site revision label Revision: v3.4.2 was added and a previous government funding notice was removed; no study content or results appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:41:30.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide funding notice and an update from v3.4.0 to v3.4.1 were added. These changes do not affect the study content or its visible details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:49:22.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page adds a glossary toggle, standardizes capitalization for labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and introduces a new revision tag 'Revision: v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-27T23:30:12.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3; this is a minor metadata update that does not affect study details or user interactions.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:25.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A unified Locations section listing study sites by state (California, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Texas) was added, and the previous state-specific location subsections were removed. The revision tag updated from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:23:37.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.3.2 replaces v3.3.1 on the page, indicating a minor version update with no changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:07.000Z thumbnail image

Stay in the know with updates to Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab/Nivolumab Combo in Hodgkin Lymphoma Clinical Trial page.